Ridinilazole (previously known as SMT19969) is an investigational small molecule antibiotic being evaluated for oral administration to treat Clostridioides...
6 KB (520 words) - 16:05, 6 June 2023
are under development and include rifalazil, tigecycline, ramoplanin, ridinilazole, and SQ641. Research has studied whether the appendix has any importance...
98 KB (10,426 words) - 08:38, 26 August 2024
will serve as CEO without compensation. Summit is focused on developing ridinilazole, a potential new treatment for C. difficile. Duggan is the founder of...
25 KB (2,371 words) - 10:14, 11 July 2024
of antibiotic resistant infections in humans. Cadazolid Fidaxomicin Ridinilazole Surotomycin US 10662164, Chang M, Mobashery S, Spink E, Ding D, Testero...
4 KB (256 words) - 23:51, 11 November 2023
collaborators played a key role in the design of a novel antibiotic, ridinilazole, which has recently been assessed in phase III clinical trials for the...
14 KB (1,423 words) - 16:29, 7 April 2024
displaying little toxicity even in regimes involving large doses. Fidaxomicin Ridinilazole SCHEMBL19952957 Surotomycin Boschert S (19 September 2012). "Promising...
5 KB (311 words) - 09:38, 11 March 2024
due to its non-superiority to current therapies. Cadazolid Fidaxomicin Ridinilazole SCHEMBL19952957 "Surotomycin Fact Sheet" (PDF). cubist.com. P Daley;...
5 KB (153 words) - 19:57, 19 March 2024